Microdose Study of Melphalan, Bortezomib and Dexamethasone

Clinical trial NCT02109861 · UNKNOWN

Trial details

NCT number: NCT02109861
Sponsor: Henrik Gregersen
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2014-01-01
Primary completion: 2015-12-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.